Skip to main content

Animations

MJFF Publications

1871 - 1880 of 8404 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022
    Journal Name: Pharmacoepidemiology and Drug Safety
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pds.5518
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Atypical Parkinsonism with Pathological Dopamine Transporter Imaging in Neuronal Ceroid Lipofuscinosis Type 5
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13562
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Autonomic changes in Huntington’s disease correlate with altered central autonomic network connectivity
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac253
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Concerns About the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29210
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Early‐Onset Neurodevelopmental Movement Disorder Secondary to Novel Mutation in KCNN2
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13535
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Levodopa Responsive Dystonia Parkinsonism, Intellectual Disability, and Optic Atrophy Due to a Heterozygous Missense Variant in AFG3L2
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13538
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Microglia: Friend and foe in tauopathy
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102306
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Neurofilament light as a biomarker for motor decline in Parkinson’s disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2022.959261
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health
    Journal Name: Trends in Molecular Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.molmed.2022.06.005
    Citation Count: 42
  • Summary Details
    RESTRICTED
    Title: Remodeling of the Cortical Structural Connectome in Posttraumatic Stress Disorder: Results From the ENIGMA-PGC Posttraumatic Stress Disorder Consortium
    Journal Name: Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.bpsc.2022.02.008
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.